M Nagori1, V S Narain2, R K Saran2, S K Dwivedi2, R Sethi2. 1. Department of Cardiology, KGMU, LKO, UP, India. Electronic address: madhuri.nagori@yahoo.co.in. 2. Department of Cardiology, KGMU, LKO, UP, India.
Abstract
OBJECTIVES: To compare the safety and diagnostic efficacy of coronary computed tomography angiography (CTA) with exercise electrocardiography (XECG) in triaging patients of low risk acute chest pain. BACKGROUND: Noninvasive assessment of coronary stenosis by CTA may improve early and accurate triage of patients presenting with acute chest pain to the emergency department (ED). METHODS: Low risk patients of possible acute coronary syndrome (ACS) were included in the study. The patients in CTA arm with significant stenosis (≥ 50%) underwent catheterization, while those with no or intermediate stenosis (<50%) were discharged from ED and followed up periodically for six months for major adverse cardiovascular events (MACE). The same protocol was applied for XECG arm. Outcomes included: safety and diagnostic efficacy. RESULTS: A total of 81 (41 CTA and 40 XECG) patients were enrolled. In this study CTA was observed to be 100% sensitive and 95.7% specific in diagnosing MACE in low risk patients of chest pain presenting to the ED, with a PPV of 94.7% and an NPV of 100%.The overall diagnostic efficacy was 97.6%. XECG was observed to be 72.7% sensitive and 96.6% specific in diagnosing MACE with a PPV of 88.9% and NPV of 90.3% in low risk chest pain patients presenting to the ED. The overall diagnostic accuracy was 90%. CONCLUSION: CTA is an excellent diagnostic tool in ED patients with low risk of ACS, with minimum time delay as compared to XECG, and also is safe for triaging such patients.
OBJECTIVES: To compare the safety and diagnostic efficacy of coronary computed tomography angiography (CTA) with exercise electrocardiography (XECG) in triaging patients of low risk acute chest pain. BACKGROUND: Noninvasive assessment of coronary stenosis by CTA may improve early and accurate triage of patients presenting with acute chest pain to the emergency department (ED). METHODS: Low risk patients of possible acute coronary syndrome (ACS) were included in the study. The patients in CTA arm with significant stenosis (≥ 50%) underwent catheterization, while those with no or intermediate stenosis (<50%) were discharged from ED and followed up periodically for six months for major adverse cardiovascular events (MACE). The same protocol was applied for XECG arm. Outcomes included: safety and diagnostic efficacy. RESULTS: A total of 81 (41 CTA and 40 XECG) patients were enrolled. In this study CTA was observed to be 100% sensitive and 95.7% specific in diagnosing MACE in low risk patients of chest pain presenting to the ED, with a PPV of 94.7% and an NPV of 100%.The overall diagnostic efficacy was 97.6%. XECG was observed to be 72.7% sensitive and 96.6% specific in diagnosing MACE with a PPV of 88.9% and NPV of 90.3% in low risk chest painpatients presenting to the ED. The overall diagnostic accuracy was 90%. CONCLUSION: CTA is an excellent diagnostic tool in ED patients with low risk of ACS, with minimum time delay as compared to XECG, and also is safe for triaging such patients.
Authors: Michael J Gallagher; Michael A Ross; Gilbert L Raff; James A Goldstein; William W O'Neill; Brian O'Neil Journal: Ann Emerg Med Date: 2006-09-15 Impact factor: 5.721
Authors: J H Pope; T P Aufderheide; R Ruthazer; R H Woolard; J A Feldman; J R Beshansky; J L Griffith; H P Selker Journal: N Engl J Med Date: 2000-04-20 Impact factor: 91.245
Authors: Judd E Hollander; Harold I Litt; Maureen Chase; Aaron M Brown; Woojin Kim; William G Baxt Journal: Acad Emerg Med Date: 2007-02 Impact factor: 3.451
Authors: James A Goldstein; Michael J Gallagher; William W O'Neill; Michael A Ross; Brian J O'Neil; Gilbert L Raff Journal: J Am Coll Cardiol Date: 2007-02-12 Impact factor: 24.094
Authors: Ricardo C Cury; Gudrun Feutchner; Constantino S Pena; Warren R Janowitz; Barry T Katzen; Jack A Ziffer Journal: J Nucl Cardiol Date: 2008 Jul-Aug Impact factor: 5.952
Authors: W Bob Meijboom; Matthijs F L Meijs; Joanne D Schuijf; Maarten J Cramer; Nico R Mollet; Carlos A G van Mieghem; Koen Nieman; Jacob M van Werkhoven; Gabija Pundziute; Annick C Weustink; Alexander M de Vos; Francesca Pugliese; Benno Rensing; J Wouter Jukema; Jeroen J Bax; Mathias Prokop; Pieter A Doevendans; Myriam G M Hunink; Gabriel P Krestin; Pim J de Feyter Journal: J Am Coll Cardiol Date: 2008-12-16 Impact factor: 24.094
Authors: Udo Hoffmann; Fabian Bamberg; Claudia U Chae; John H Nichols; Ian S Rogers; Sujith K Seneviratne; Quynh A Truong; Ricardo C Cury; Suhny Abbara; Michael D Shapiro; Jamaluddin Moloo; Javed Butler; Maros Ferencik; Hang Lee; Ik-Kyung Jang; Blair A Parry; David F Brown; James E Udelson; Stephan Achenbach; Thomas J Brady; John T Nagurney Journal: J Am Coll Cardiol Date: 2009-05-05 Impact factor: 24.094
Authors: Julie M Miller; Carlos E Rochitte; Marc Dewey; Armin Arbab-Zadeh; Hiroyuki Niinuma; Ilan Gottlieb; Narinder Paul; Melvin E Clouse; Edward P Shapiro; John Hoe; Albert C Lardo; David E Bush; Albert de Roos; Christopher Cox; Jeffery Brinker; João A C Lima Journal: N Engl J Med Date: 2008-11-27 Impact factor: 91.245